PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Rakai Health Sciences Program, P.O. Box 279, Kalisizo, Uganda. cssuuna@rhsp.org.\', \'Rakai Health Sciences Program, P.O. Box 279, Kalisizo, Uganda.\', \'Makerere University School of Public Health, Kampala, Uganda.\', \'Uganda Virus Research Institute, Entebbe, Uganda.\', \'Kyotera District Health Office, Kyotera District Local Government, Ministry of Health, Kyotera, Uganda.\', \'Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Division of Infectious Disease, Division of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.\', \'Abbott Laboratories, Abbott Diagnostics Division, Abbott Park, IL, USA.\', \'Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1186/s12879-022-07161-4
?:hasPublicationType
?:journal
  • BMC infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 35189840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.576
?:rankingScore_hIndex
  • 80
is ?:relation_isRelatedTo_publication of
?:title
  • Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all